ARCA Biopharma Price Prediction
As of today the value of rsi of ARCA Biopharma's share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.
The successful prediction of ARCA Biopharma's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with ARCA Biopharma, which may create opportunities for some arbitrage if properly timed.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Oversold Vs Overbought
0
Oversold | Overbought |
Using ARCA Biopharma hype-based prediction, you can estimate the value of ARCA Biopharma from the perspective of ARCA Biopharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in ARCA Biopharma to buy its stock at a price that has no basis in reality. In that case, they are not buying ARCA because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ARCA Biopharma after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
ARCA |
ARCA Biopharma After-Hype Price Prediction Density Analysis
As far as predicting the price of ARCA Biopharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ARCA Biopharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ARCA Biopharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ARCA Biopharma Estimiated After-Hype Price Volatility
In the context of predicting ARCA Biopharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ARCA Biopharma's historical news coverage. ARCA Biopharma's after-hype downside and upside margins for the prediction period are 0.00 and 50.00, respectively. We have considered ARCA Biopharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ARCA Biopharma is out of control at this time. Analysis and calculation of next after-hype price of ARCA Biopharma is based on 3 months time horizon.
ARCA Biopharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as ARCA Biopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ARCA Biopharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ARCA Biopharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
40.11 | 65.90 | 15.24 | 5.67 | 8 Events / Month | 15 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.00 | 0.00 | 0.00 |
|
ARCA Biopharma Hype Timeline
ARCA Biopharma is presently traded for 0.00. The entity has historical hype elasticity of -15.24, and average elasticity to hype of competition of -5.67. ARCA is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at -40.11%. %. The volatility of related hype on ARCA Biopharma is about 46617.36%, with the expected price after the next announcement by competition of -5.67. About 99.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 5.88. ARCA Biopharma last dividend was issued on the 29th of August 2024. The entity had 1:18 split on the 4th of April 2019. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.ARCA Biopharma Related Hype Analysis
Having access to credible news sources related to ARCA Biopharma's direct competition is more important than ever and may enhance your ability to predict ARCA Biopharma's future price movements. Getting to know how ARCA Biopharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ARCA Biopharma may potentially react to the hype associated with one of its peers.
ARCA Biopharma Additional Predictive Modules
Most predictive techniques to examine ARCA price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ARCA using various technical indicators. When you analyze ARCA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About ARCA Biopharma Predictive Indicators
The successful prediction of ARCA Biopharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ARCA Biopharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ARCA Biopharma based on analysis of ARCA Biopharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ARCA Biopharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ARCA Biopharma's related companies.
Story Coverage note for ARCA Biopharma
The number of cover stories for ARCA Biopharma depends on current market conditions and ARCA Biopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ARCA Biopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ARCA Biopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
ARCA Biopharma Short Properties
ARCA Biopharma's future price predictability will typically decrease when ARCA Biopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ARCA Biopharma often depends not only on the future outlook of the potential ARCA Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ARCA Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 14.4 M | |
| Cash And Short Term Investments | 37.4 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in ARCA Stock
If you are still planning to invest in ARCA Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ARCA Biopharma's history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |